(Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today reported financial results for the fourth quarter and full-year ...

Aurora Mobile Limited (“Aurora Mobile” or the “Company”) (NASDAQ: JG), a leading provider of customer engagement and marketing technology services in China, today announced its unaudited financial ...

Achieved record gross bookings of $65.8 million and revenue of $59.7 million in full-year 2024 Signed 46 new customers in 2024 and expanded relationship with existing customers across key markets ...

Recent balance sheet actions position the Company for future growth PLANO, TX / ACCESS Newswire / February 27, 2025 / Intrusion Inc.

The complaint, filed in February 2025, claims the death of Roma Gupta and her daughter's "catastrophic injuries" were ...

Urgent.ly Inc. (Nasdaq: ULY) ("Urgently"), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today reported ...

Mumbai had earlier admitted a Section 9 application under the Insolvency and Bankruptcy Code (IBC) filed by Alcuris Healthcare, treating the outstanding dues as operational debt. However, the NCLAT ...

(Nasdaq: BLZE), the cloud storage innovator delivering a modern alternative to traditional cloud providers, today announced ...

In early UK corporate news, Legal & General announced a buyback, 4imprint a special dividend, and Hill & Smith said its US offering has impressed. Here is what you need to know at the London market ...

Recent balance sheet actions position the Company for future growth PLANO, TX / ACCESS Newswire / February 27, 2025 / Intrusion Inc. (NASDAQ:INTZ) ("Intrusion" or the "Company"), a leader in cyberatta ...

Ontrak, Inc. (NASDAQ: OTRK), a leading AI-powered and telehealth-enabled behavioral healthcare company, today announced it has signed an extension ... Such forward-looking statements are current only ...

Advanced oncology pipeline including more than 20 active Phase 2 and Phase 3 clinical trials with a strategic focus on two priority pan- ...